Polaprezinc prevents oral mucositis in patients treated with high-dose chemotherapy followed by hematopoietic stem cell transplantation
H Hayashi, R Kobayashi, A Suzuki… - Anticancer …, 2014 - ar.iiarjournals.org
We have previously reported that polaprezinc in sodium alginate suspension (P-AG)
inhibited the incidence of oral mucositis induced by radiochemotherapy in patients with …
inhibited the incidence of oral mucositis induced by radiochemotherapy in patients with …
Polaprezinc prevents oral mucositis associated with radiochemotherapy in patients with head and neck cancer
T Watanabe, M Ishihara, K Matsuura… - … journal of cancer, 2010 - Wiley Online Library
Oral mucositis is frequent but serious adverse event associated with radiotherapy or
radiochemotherapy in head and neck cancer severely impairs health‐related quality of life …
radiochemotherapy in head and neck cancer severely impairs health‐related quality of life …
[HTML][HTML] Polaprezinc reduces the severity of radiation-induced mucositis in head and neck cancer patients
H Doi, M Fujiwara, H Suzuki, Y Niwa… - … and Clinical Oncology, 2015 - ncbi.nlm.nih.gov
Polaprezinc (PZ), an antiulcer drug, has been reported to have antioxidant properties. The
aim of the present study was to assess the feasibility and efficacy of administering PZ for …
aim of the present study was to assess the feasibility and efficacy of administering PZ for …
Effect of polaprezinc on oral mucositis, irradiation period, and time to discharge in patients with head and neck cancer
A Suzuki, R Kobayashi, T Shakui, Y Kubota… - Head & …, 2016 - Wiley Online Library
Background The purpose of the present study was to determine whether polaprezinc
suspension in sodium alginate (P‐AG) reduces the irradiation period and time to discharge …
suspension in sodium alginate (P‐AG) reduces the irradiation period and time to discharge …
[HTML][HTML] Preparation and clinical evaluation of a novel lozenge containing polaprezinc, a zinc-L-carnosine, for prevention of oral mucositis in patients with …
H Hayashi, R Kobayashi, A Suzuki, Y Yamada… - Medical Oncology, 2016 - Springer
We previously reported that oral ingestion of polaprezinc, a zinc-L-carnosine, suspended in
sodium alginate solution prevents oral mucositis in patients receiving radiotherapy or high …
sodium alginate solution prevents oral mucositis in patients receiving radiotherapy or high …
Polaprezinc for prevention of oral mucositis in patients receiving chemotherapy followed by hematopoietic stem cell transplantation: A multi‐institutional randomized …
J Kitagawa, R Kobayashi, Y Nagata… - … Journal of Cancer, 2021 - Wiley Online Library
Oral mucositis is a common and distressing complication in patients receiving high‐dose
chemotherapy followed by hematopoietic stem cell transplantation (HSCT). We reported …
chemotherapy followed by hematopoietic stem cell transplantation (HSCT). We reported …
Prophylactic effect of polaprezinc, a zinc-L-carnosine, against chemotherapy-induced oral mucositis in pediatric patients undergoing autologous stem cell …
M Funato, M Ozeki, A Suzuki, M Ishihara… - Anticancer …, 2018 - ar.iiarjournals.org
Background/Aim: Polaprezinc suspension in sodium alginate (PZ-AG) reduces the incidence
and severity of oral mucositis in adult patients receiving radiotherapy or high-dose …
and severity of oral mucositis in adult patients receiving radiotherapy or high-dose …
Oral zinc sulphate and prevention of radiation-induced oropharyngealmucositis in patients with head and neck cancers: a double blind, randomized controlled clinical …
D Moslemi, N Babaee, M Damavandi… - 2014 - sid.ir
Background: This research was conducted to evaluate the potential benefits of zinc sulphate
in the PREVENTION of radiation induced MUCOSITIS in patients who are being treated for …
in the PREVENTION of radiation induced MUCOSITIS in patients who are being treated for …
Utility of polaprezinc in reducing toxicities during radiotherapy: a literature review
H Doi, K Kuribayashi, T Kijima - Future Oncology, 2018 - Future Medicine
Chemoradiotherapy is important for treating malignancies. However, radiation-induced
toxicities develop as chemoradiotherapy-related complications. Various agents reduce or …
toxicities develop as chemoradiotherapy-related complications. Various agents reduce or …
Efficacy of improvised topical zinc (1%) ora-base on oral mucositis during cancer chemo-radiation—A randomized study
NC CHAITANYA, R Badam, AS Aryasri… - Journal of Nutritional …, 2020 - jstage.jst.go.jp
Oral mucositis refers to erythematous and ulcerative lesions of oral mucosa during
chemo/radiotherapy. Treatment modalities were directed towards reduction in severity of …
chemo/radiotherapy. Treatment modalities were directed towards reduction in severity of …
Related searches
- neck cancer oral mucositis
- patients with head oral mucositis
- zinc l carnosine oral mucositis
- effect of polaprezinc oral mucositis
- irradiation period oral mucositis
- chemo radiation oral mucositis
- patients with head neck cancer
- effect of polaprezinc neck cancer
- clinical evaluation oral mucositis
- neck cancers zinc sulphate
- irradiation period neck cancer
- patients with head effect of polaprezinc
- patients with head irradiation period
- patients with head zinc sulphate
- radiochemotherapy in patients oral mucositis
- pediatric patients oral mucositis